Xtant Medical Holdings (XTNT) Q1 2024 Annual Earnings
XTNT·Reported May 15, 2024·After market close
Xtant Medical Holdings reported Q1 2024 revenue of $27.9M, beat analyst consensus of $25.8M by $2.1M. Diluted EPS came in at $-0.03, missed the $-0.01 consensus by $0.01.
Revenue
$27.9Mbeat by $2.1M
Consensus: $25.8MDiluted EPS
$-0.03missed by $0.01
Consensus: $-0.01
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Xtant Medical Holdings's Q1 2024 earnings report.
Xtant Medical Holdings (XTNT) reported Q1 2024 earnings on May 15, 2024 after market close.
Xtant Medical Holdings reported revenue of $27.9M and diluted EPS of $-0.03 for Q1 2024.
Revenue beat the consensus estimate of $25.8M by $2.1M. EPS missed the consensus estimate of $-0.01 by $0.01.
You can read the 10-K periodic report (0001493152-24-012145) directly on SEC EDGAR. The filing index links above go to sec.gov.